Gossamer Bio, Inc. (GOSS)
2.52
+0.07
(+2.86%)
USD |
NASDAQ |
Jan 16, 16:00
2.60
+0.08
(+3.17%)
After-Hours: 20:00
Gossamer Bio Profit Margin (Quarterly): -362.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -39.75% |
| XOMA Royalty Corp. | -- |
| Rezolute, Inc. | -- |
| Axsome Therapeutics, Inc. | -27.62% |
| Crinetics Pharmaceuticals, Inc. | -90.97K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -55.91% |
| Return on Invested Capital | -81.00% |
| Gross Profit Margin (Quarterly) | 98.35% |
| Operating Margin (Quarterly) | -313.2% |
| Return on Net Operating Assets | -1.44K% |